Breaking News Instant updates and real-time market news.

MNRO

Monro

$82.23 /

-0.15 (-0.18%)

05:33
07/11/19
07/11
05:33
07/11/19
05:33

Monro downgraded to Perform from Outperform at Oppenheimer

Oppenheimer analyst Brian Nagel downgraded Monro to Perform from Outperform.

  • 13

    Nov

MNRO Monro
$82.23 /

-0.15 (-0.18%)

05/22/19 SunTrust
Monro price target raised to $85 from $72 at SunTrust
04/04/19
Monro downgraded to Neutral at Guggenheim on near-peak valuation
04/04/19 Guggenheim
Monro downgraded to Neutral from Buy at Guggenheim
11/06/18 Oppenheimer
Monro price target raised to $86 from $70 at Oppenheimer

TODAY'S FREE FLY STORIES

Earnings
Acceleron Pharma reports Q4 EPS (44c), consensus (30c) » 16:06
02/27/20
02/27
16:06
02/27/20
16:06
XLRN

Acceleron

$86.99 /

-0.08 (-0.09%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Rigel Pharmaceuticals reports Q4 EPS (10c), consensus (8c) » 16:05
02/27/20
02/27
16:05
02/27/20
16:05
RIGL

Rigel Pharmaceuticals

$2.08 /

-0.1 (-4.59%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Axon reports Q4 EPS 41c, consensus 38c » 16:05
02/27/20
02/27
16:05
02/27/20
16:05
AAXN

Axon

$78.09 /

-2.375 (-2.95%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Collegium Pharmaceutical reports Q4 EPS (7c), consensus (10c) » 16:05
02/27/20
02/27
16:05
02/27/20
16:05
COLL

Collegium Pharmaceutical

$21.84 /

-0.74 (-3.28%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Novan files to sell common stock, no amount given » 16:05
02/27/20
02/27
16:05
02/27/20
16:05
NOVN

Novan

$0.33 /

-0.1174 (-26.09%)

H.C. Wainwright & Co.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
iCAD reports Q4 EPS (10c), consensus (12c) » 16:04
02/27/20
02/27
16:04
02/27/20
16:04
ICAD

iCAD

$10.54 /

-0.78 (-6.89%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Mylan sees FY20 revenues of $11.5B-$12.5B, consensus $11.92B » 16:04
02/27/20
02/27
16:04
02/27/20
16:04
MYL

Mylan

$18.85 /

-0.71 (-3.63%)

Mylan is providing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Autodesk sees FY20 EPS $4.21-$4.44, consensus $4.41 » 16:03
02/27/20
02/27
16:03
02/27/20
16:03
ADSK

Autodesk

$183.17 /

-7.72 (-4.04%)

Sees FY20 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Gulfport Energy reports Q4 EPS 5c, consensus 18c » 16:03
02/27/20
02/27
16:03
02/27/20
16:03
GPOR

Gulfport Energy

$0.92 /

-0.085 (-8.46%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Autodesk sees Q1 EPS 80c-86c, consensus 88c » 16:03
02/27/20
02/27
16:03
02/27/20
16:03
ADSK

Autodesk

$183.27 /

-7.62 (-3.99%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Spectrum reports Q4 EPS (30c), consensus (33c) » 16:02
02/27/20
02/27
16:02
02/27/20
16:02
SPPI

Spectrum

$2.48 /

-0.13 (-4.98%)

Spectrum reported cash,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Mylan reports Q4 adjusted EPS $1.40, consensus $1.28 » 16:02
02/27/20
02/27
16:02
02/27/20
16:02
MYL

Mylan

$18.83 /

-0.73 (-3.73%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Immunomedics reports Q4 EPS (50c), consensus (46c) » 16:02
02/27/20
02/27
16:02
02/27/20
16:02
IMMU

Immunomedics

$16.16 /

-0.21 (-1.28%)

Reports Q4 revenue $295K…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Trade Desk sees FY20 revenue at least $863M, consensus $859.98M » 16:02
02/27/20
02/27
16:02
02/27/20
16:02
TTD

Trade Desk

$253.91 /

-13.09 (-4.90%)

Sees FY20 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Autodesk reports Q4 EPS 92c, consensus 89c » 16:02
02/27/20
02/27
16:02
02/27/20
16:02
ADSK

Autodesk

$183.37 /

-7.52 (-3.94%)

Reports Q4 revenue $899M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Trade Desk sees Q1 revenue $169M, consensus $161.16M » 16:02
02/27/20
02/27
16:02
02/27/20
16:02
TTD

Trade Desk

$253.35 /

-13.65 (-5.11%)

Sees Q1 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Afterpay downgraded to Neutral from Conviction Buy at Goldman Sachs » 16:01
02/27/20
02/27
16:01
02/27/20
16:01
AFTPF

Afterpay

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Trade Desk reports Q4 adjusted EPS $1.49, consensus $1.17 » 16:01
02/27/20
02/27
16:01
02/27/20
16:01
TTD

Trade Desk

$253.35 /

-13.65 (-5.11%)

Reports Q4 revevnue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Pretium Resources put volume heavy and directionally bearish » 15:55
02/27/20
02/27
15:55
02/27/20
15:55
PVG

Pretium Resources

$7.53 /

-0.43 (-5.40%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Flushing Financial receives Empire shareholder approval for pending acquisition » 15:51
02/27/20
02/27
15:51
02/27/20
15:51
FFIC

Flushing Financial

$18.77 /

-0.4 (-2.09%)

Flushing Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Kinder Morgan call volume above normal and directionally bullish » 15:45
02/27/20
02/27
15:45
02/27/20
15:45
KMI

Kinder Morgan

$19.74 /

-0.775 (-3.78%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Microsoft's LinkedIn experimenting with Stories feature internally » 15:42
02/27/20
02/27
15:42
02/27/20
15:42
MSFT

Microsoft

$161.40 /

-8.8 (-5.17%)

, SNAP

Snap

$14.91 /

-0.775 (-4.94%)

Microsoft (MSFT) unit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Vaxart announces $10M registered direct offering priced at-the-market » 15:38
02/27/20
02/27
15:38
02/27/20
15:38
VXRT

Vaxart

$2.57 /

+0.92 (+55.76%)

Vaxart announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Tai Lopez interested in Blue Apron acquisition, NY Post says » 15:35
02/27/20
02/27
15:35
02/27/20
15:35
APRN

Blue Apron

$2.41 /

+0.16 (+7.11%)

Los Angeles tech investor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Sunrun options imply 17.6% move in share price post-earnings » 15:34
02/27/20
02/27
15:34
02/27/20
15:34
RUN

Sunrun

$20.65 /

-0.28 (-1.34%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.